70
Views
0
CrossRef citations to date
0
Altmetric
Review

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin

Pages 243-252 | Published online: 27 Sep 2022

Figures & data

Figure 1 Pleotrophic effects of pioglitazone. Modifying the adipocytokine syndrome: a model relating obesity, insulin resistance, and beta cell dysfunction and atherosclerotic cardiovascular disease.

Figure 1 Pleotrophic effects of pioglitazone. Modifying the adipocytokine syndrome: a model relating obesity, insulin resistance, and beta cell dysfunction and atherosclerotic cardiovascular disease.